Navigation Links
Recurrence of aggressive uterine cancer reduced by new form of therapy

The incidence of uterine papillary serous carcinoma (UPSC) has increased since it was first identified in 1981. The condition was initially regarded as easy to treat until about 1990 when a number of persons were diagnosed with the // aggressive cancer. It has remained a significant problem since then.

UPSC is found in higher rates in African American women than in white women. The disease looks like ovarian cancer and spreads just as rapidly, restricting the choice of treatment to only chemotherapy.

A state-of-the-art treatment program now developed at Yale School of Medicine has been found to increase survival from the aggressive uterine papillary serous carcinoma (UPSC) sparing the need for additional therapy in some patients.

According to the study, it has been that a combination of platinum-based chemotherapy and vaginal radiation to be the most effective treatment for the disease. This has infact led to the establishment of a standard of care being established for this type of uterine cancer.

Moreover, it can also be used to evaluate the need for additional treatment following surgery and hence determine the prognosis. The survival rates of women have considerably increased with reduction in the recurrence rates.

The study was conducted on a group of 74 patients with UPSC who underwent complete surgical staging, or hysterectomy with removal of lymph nodes and fat pads. Cancer recurred in 43 percent of early stage patients who did not receive chemotherapy, while in the 20 percent of patients who received platinum-based chemotherapy there were no recurrences. About 14 patients were spared additional radiation treatment.

Page: 1

Related medicine news :

1. Lowering Risk of Breast Cancer Recurrence
2. HRT Found To Increase Recurrence of Breast Cancer
3. The Link Between HRT And Recurrence of Breast Cancer
4. Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available
5. Predicting Breast Cancer Recurrence By Understanding Gene Signature
6. Combination Therapy To Avoid Prostate Cancer Recurrence
7. Cervical Cancer Recurrence Risk Even After Removal Of Pre-Cancerous Cells
8. Drugs Are Effective In Treating Depression and Preventing Recurrence
9. PET-CT Scores High On Precision for Diagnosing Ovarian Cancer Recurrence
10. Experts Warn of Bird Flu Recurrence in Maharashtra
11. Petition On Recurrence Of Dengue And Malaria In Kolkata
Post Your Comments:

(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
Breaking Medicine Technology: